Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-15 Purchase |
2023-11-17 5:03 pm |
VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director |
13,000 | $3.906 | $50,778 | 36,472 (Direct) |
View |
| 2023-03-20 Purchase |
2023-03-22 4:03 pm |
VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director |
20,000 | $2.484 | $49,680 | 23,472 (Direct) |
View |
| 2023-03-20 Purchase |
2023-03-22 4:01 pm |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
10,000 | $2.5 | $25,000 | 22,721 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-01 Option Award |
2024-01-03 5:10 pm |
N/A 2033-12-31 |
VYNE Therapeutics Inc. | VYNE | Basta Steven L Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-03 5:09 pm |
N/A 2033-12-31 |
VYNE Therapeutics Inc. | VYNE | BARBARI SHARON Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-03 5:07 pm |
N/A 2033-12-31 |
VYNE Therapeutics Inc. | VYNE | Borowski Christine Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-12-13 Option Award |
2023-12-15 5:11 pm |
N/A 2033-12-12 |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Chief Financial Officer |
62,500 | $0 | 131,930 (Direct) |
View |
| 2023-12-13 Option Award |
2023-12-15 5:10 pm |
N/A 2033-12-12 |
VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer |
62,500 | $0 | 134,055 (Direct) |
View |
| 2023-12-13 Option Award |
2023-12-15 5:09 pm |
N/A 2033-12-12 |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
62,500 | $0 | 149,596 (Direct) |
View |
| 2023-12-13 Option Award |
2023-12-15 5:08 pm |
N/A 2033-12-12 |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
225,000 | $0 | 496,168 (Direct) |
View |
| 2023-12-13 Option Award |
2023-12-15 5:06 pm |
N/A 2033-12-12 |
VYNE Therapeutics Inc. | VYNE | Sandoval Elisabeth Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-12-13 Option Award |
2023-12-15 5:05 pm |
N/A 2033-12-12 |
VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-12-13 Option Award |
2023-12-15 5:04 pm |
N/A 2033-12-12 |
VYNE Therapeutics Inc. | VYNE | Bruno Anthony D Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-12-13 Option Award |
2023-12-15 5:02 pm |
N/A 2033-12-12 |
VYNE Therapeutics Inc. | VYNE | Basta Steven L Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-12-13 Option Award |
2023-12-15 5:01 pm |
N/A 2033-12-12 |
VYNE Therapeutics Inc. | VYNE | BARBARI SHARON Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-11-30 Option Award |
2023-12-04 4:30 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
2,284 | $2.8135 | 46,168 (Direct) |
View |
Ownership |
2023-11-13 08:30 am |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | AI Biotechnology LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner |
0 | $0 | 8,909,033 (Direct) |
View |
| 2023-10-02 Tax Withholding |
2023-10-04 4:26 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Chief Financial Officer |
1,087 | $3.83 | 6,930 (Direct) |
View |
| 2023-10-02 Tax Withholding |
2023-10-04 4:23 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer |
1,184 | $3.83 | 9,055 (Direct) |
View |
| 2023-10-02 Tax Withholding |
2023-10-04 4:21 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
1,154 | $3.83 | 24,596 (Direct) |
View |
| 2023-10-02 Tax Withholding |
2023-10-04 4:19 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
8,549 | $3.83 | 43,884 (Direct) |
View |
| 2023-06-30 Tax Withholding |
2023-07-05 4:37 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Chief Financial Officer |
91 | $4.1 | 8,017 (Direct) |
View |
| 2023-06-30 Tax Withholding |
2023-07-05 4:34 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer |
151 | $4.1 | 10,239 (Direct) |
View |
| 2023-06-30 Tax Withholding |
2023-07-05 4:32 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
157 | $4.1 | 25,750 (Direct) |
View |
| 2023-06-30 Tax Withholding |
2023-07-05 4:30 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
981 | $4.1 | 52,433 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 4:34 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
3,664 | $3.4563 | 25,907 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 4:31 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
2,766 | $3.4563 | 53,414 (Direct) |
View |
| 2023-03-31 Tax Withholding |
2023-04-04 5:07 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Chief Financial Officer |
384 | $3.08 | 8,108 (Direct) |
View |
| 2023-03-31 Tax Withholding |
2023-04-04 5:05 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer |
480 | $3.08 | 10,390 (Direct) |
View |
| 2023-03-31 Tax Withholding |
2023-04-04 5:03 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
478 | $3.08 | 22,243 (Direct) |
View |
| 2023-03-31 Tax Withholding |
2023-04-04 5:01 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
2,734 | $3.08 | 50,648 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-04 5:12 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
1,813 | $0.15 | 229,144 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-04 5:09 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer |
1,720 | $0.15 | 220,252 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-04 5:05 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Chief Financial Officer |
354 | $0.15 | 173,005 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-04 5:03 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
10,685 | $0.15 | 1,064,290 (Direct) |
View |
| 2022-11-30 Option Award |
2022-12-02 4:30 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
34,705 | $0.1977 | 1,074,975 (Direct) |
View |
| 2022-09-30 Tax Withholding |
2022-10-04 5:05 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler CFO |
353 | $0.223 | 173,359 (Direct) |
View |
| 2022-09-30 Tax Withholding |
2022-10-04 5:05 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer |
1,719 | $0.223 | 221,972 (Direct) |
View |
| 2022-09-30 Tax Withholding |
2022-10-04 5:04 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
1,813 | $0.223 | 230,957 (Direct) |
View |